Pain in Hidradenitis Suppurativa: A Cross-sectional Study of 1,795 Patients
DOI:
https://doi.org/10.2340/00015555-3724Keywords:
hidradenitis suppurativa, acne inversa, numerical rating scaleAbstract
Hidradenitis suppurativa is a chronic, inflammatory skin disorder that affects the pilosebaceous unit of the intertriginous body areas. Pain is one of the most important problems in patients with hidradenitis suppurativa. The aim of this study, which included 1,795 patients, was to evaluate the prevalence and characteristics of pain. The intensity of pain was assessed with a numerical rating scale. In addition, pain intensity was correlated with various clinical features. Pain was reported by 83.6% of subjects. The majority of patients (77.6%) experienced mild pain; women and smokers tended to experience more intense pain. Pain intensity was greater in patients with multiple affected skin areas and correlated positively with the number of those affected areas (r = 0.151, p < 0.001). There was no difference in pain intensity between affected locations. The worst pain was observed in the patients with the most severe disease and it would weaken significantly along with the severity of hidradenitis suppurativa (assessed using the Hurley staging system and the International Hidradenitis Suppurativa Severity Score System).
Downloads
References
Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol 2015; 29: 619-644.
DOI: https://doi.org/10.1111/jdv.12966
Lee JH, Kwon HS, Jung HM, Kim GM, Bae JM. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol 2018; 32: 1784-1790.
DOI: https://doi.org/10.1111/jdv.15071
Schneider-Burrus S, Lux G, van der Linde K, Barbus S, Huss-Marp J, Tsaousi A, et al. Hidradenitis suppurativa - prevalence analyses of German statutory health insurance data. J Eur Acad Dermatol Venereol 2020 Jun 24. [Epub ahead of print].
DOI: https://doi.org/10.1111/jdv.16783
Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996; 35: 191-194.
DOI: https://doi.org/10.1016/S0190-9622(96)90321-7
Sabat R, Jemec GBE, Matusiak L, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020; 6: 18.
DOI: https://doi.org/10.1038/s41572-020-0149-1
Cuenca-Barrales C, Molina-Leyva A. Risk factors of sexual dysfunction in patients with hidradenitis suppurativa: a cross-sectional study. Dermatology 2020; 236: 37-45.
DOI: https://doi.org/10.1159/000501905
Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 2010; 90: 264-268.
DOI: https://doi.org/10.2340/00015555-0866
Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol 2013; 133: 97-103.
DOI: https://doi.org/10.1038/jid.2012.255
Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010; 62: 706-708, 8 e1.
DOI: https://doi.org/10.1016/j.jaad.2009.09.021
Kaaz K, Szepietowski JC, Matusiak L. Influence of itch and pain on sleep quality in patients with hidradenitis suppurativa. Acta Derm Venereol 2018; 98: 757-761.
DOI: https://doi.org/10.2340/00015555-2967
Matusiak L, Szczech J, Kaaz K, Lelonek E, Szepietowski JC. Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa. Acta Derm Venereol 2018; 98: 191-194.
DOI: https://doi.org/10.2340/00015555-2815
Ring HC, Sorensen H, Miller IM, List EK, Saunte DM, Jemec GB. Pain in hidradenitis suppurativa: a pilot study. Acta Derm Venereol 2016; 96: 554-556.
DOI: https://doi.org/10.2340/00015555-2308
Ring HC, Theut Riis P, Miller IM, Saunte DM, Jemec GB. Self-reported pain management in hidradenitis suppurativa. Br J Dermatol 2016; 174: 909-911.
DOI: https://doi.org/10.1111/bjd.14266
Nielsen RM, Lindso Andersen P, Sigsgaard V, Theut Riis P, Jemec GB. Pain perception in patients with hidradenitis suppurativa. Br J Dermatol 2020; 182: 166-174.
DOI: https://doi.org/10.1111/bjd.18656
Zouboulis CC, Del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GB. Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 2015; 231: 184-190.
DOI: https://doi.org/10.1159/000431175
Chien CW, Bagraith KS, Khan A, Deen M, Syu JJ, Strong J. Establishment of cutpoints to categorize the severity of chronic pain using composite ratings with Rasch analysis. Eur J Pain 2017; 21: 82-91.
DOI: https://doi.org/10.1002/ejp.906
Horvath B, Janse IC, Sibbald GR. Pain management in patients with hidradenitis suppurativa. J Am Acad Dermatol 2015; 73: S47-S51.
DOI: https://doi.org/10.1016/j.jaad.2015.07.046
Patel ZS, Hoffman LK, Buse DC, Grinberg AS, Afifi L, Cohen SR, et al. Pain, psychological comorbidities, disability, and impaired quality of life in hidradenitis suppurativa [corrected]. Curr Pain Headache Rep 2017; 21: 49.
DOI: https://doi.org/10.1007/s11916-017-0647-3
Huilaja L, Hirvonen MJ, Lipitsa T, Vihervaara A, Harvima R, Sintonen H, et al. Patients with hidradenitis suppurativa may suffer from neuropathic pain: a Finnish multicenter study. J Am Acad Dermatol 2020; 82: 1232-1234.
DOI: https://doi.org/10.1016/j.jaad.2019.11.016
Mailhot B, Christin M, Tessandier N, Sotoudeh C, Bretheau F, Turmel R, et al. Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases. J Exp Med 2020; 217: e20191430.
DOI: https://doi.org/10.1084/jem.20191430
Witte-Handel E, Wolk K, Tsaousi A, Irmer ML, Mossner R, Shomroni O, et al. The IL-1 Pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction. J Invest Dermatol 2019; 139: 1294-1305.
DOI: https://doi.org/10.1016/j.jid.2018.11.018
Onderdijk AJ, van der Zee HH, Esmann S, Lophaven S, Dufour DN, Jemec GB, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2013; 27: 473-478.
DOI: https://doi.org/10.1111/j.1468-3083.2012.04468.x
Hoffman LK, Ghias MH, Lowes MA. Pathophysiology of hidradenitis suppurativa. Semin Cutan Med Surg 2017; 36: 47-54.
DOI: https://doi.org/10.12788/j.sder.2017.017
Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol 2009; 161: 831-839.
DOI: https://doi.org/10.1111/j.1365-2133.2009.09198.x
Hana A, Booken D, Henrich C, Gratchev A, Maas-Szabowski N, Goerdt S, et al. Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci 2007; 80: 2214-2220.
DOI: https://doi.org/10.1016/j.lfs.2007.02.007
Gerner RR, Wieser V, Moschen AR, Tilg H. Metabolic inflammation: role of cytokines in the crosstalk between adipose tissue and liver. Can J Physiol Pharmacol 2013; 91: 867-872.
DOI: https://doi.org/10.1139/cjpp-2013-0050
Loh TY, Hendricks AJ, Hsiao JL, Shi VY. Undergarment and fabric selection in the management of hidradenitis suppurativa. Dermatology 2019 Aug 29 [Online ahead of print].
DOI: https://doi.org/10.1159/000501611
Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol 2011; 91: 328-332.
DOI: https://doi.org/10.2340/00015555-1082
von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809-813.
DOI: https://doi.org/10.1046/j.1365-2133.2001.04137.x
Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J; Quality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56: 621-623.
Published
How to Cite
License
Copyright (c) 2021 Piotr K. Krajewski, Łukasz Matusiak, Esther von Stebut, Michael Schultheis, Uwe Kirschner, Georgios Nikolakis, Jacek C. Szepietowski
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
